In vivo regulation of inducible NO synthase in immune-mediated liver injury in mice

Hepatology

Volumn 36, Issue 5, 2002, Pages 1061-1069

  Koerber, Kerstin ^a   Sass, Gabriele ^a   Kiemer, Alexandra K ^b   Vollmar, Angelika M ^b   Tiegs, Gisa ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CONCANAVALIN A; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NITRIC OXIDE SYNTHASE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLEEDING; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME ACTIVATION; ENZYME REGULATION; GEL MOBILITY SHIFT ASSAY; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; INHIBITION KINETICS; LIVER INJURY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

EID: 0036830306     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2002.36155     Document Type: Article

References (50)

1. Tilg H, Wilmer A, Vogel W, Herold M, Nölchen B, Judmaier G, Huber C. Serum levels of cytokines in chronic liver diseases. Gastroenterology 1992;103:264-274.
2. Tiegs G, Hentschel J, Wendel A. A T cell-dependent experimental liver injury in mice inducible by concanavalin A. J Clin Invest 1992;90:196-203.
3. Gantner F, Kusters S, Wendel A, Hatzelmann A, Schudt C, Tiegs G. Protection from T cell-mediated murine liver failure by phosphodiesterase inhibitors. J Pharmacol Exp Ther 1997;280:53-60.
4. Schumann J, Wolf D, Pahl A, Brune K, Papadopoulos T, van Rooijen N, Tiegs G. Importance of Kupffer cells for T-cell-dependent liver injury in mice. Am J Pathol 2000;157:1671-1683.
5. Gantner F, Leist M, Lohse AW, Germann P, and Tiegs G. Concanavalin A-induced T cell-mediated hepatic injury in mice: The role of tumor necrosis factor. Hepatology 1995;21:190-198.
6. Kusters S, Gantner F, Kunstle G, Tiegs G. Interferon gamma plays a critical role in T cell-dependent liver injury in mice initiated by concanavalin A. Gastroenterology 1996;111:462-471
7. Kusters S, Tiegs G, Alexopoulou L, Pasparakis M, Douni E, Künstle G, Bluetmann H, et al. In vivo evidence for a functional role or both TNF receptors and transmembrane TNR in experimental hepatitis. Eur J Immunol 1997;27:2870-2875.
8. Leist M, Gantner F, Jilg S, Wendel A. Activation of the 55 kDa TNF receptor is necessary and sufficient for TNF-induced liver failure, hepatocyte apoptosis, and nitrite release. J Immunol 1995;154:1307-1316.
9. Schümann J, Tiegs G. Pathophysiological mechanisms of TNF during intoxication with natural or man-made toxins. Toxicology 1999;138:103-126.
10. Curran RD, Billiar TR, Stuehr DJ, Hoffmann K, Simmons RL. Hepatocytes produce nitrogen oxides from L-arginine in response to inflammatory products of Kupffer cells. J Exp Med 1989;170:1769-1774.
11. Curran RD, Billiar TR, Stuehr DJ, Ochoa JB, Harbrecht BG, Flint SG, Simmons RL. Multiple cytokines are required to induce hepatocyte nitric oxide production and inhibit total protein sythesis. Ann Surg 1990;212:462-471.
12. Ding AH, Nathan CF, Stuehr DJ. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages: Comparison of activating cytokines and evidence for independent production. J Immunol 1988;141:2407-2412.
13. Michel T, Xie QW, Nathan C. Molecular biological analysis of nitric oxide synthases. In: Feelisch M, Stamler JS, eds. Methods of Nitric Oxide Research. Chichester: Wiley, 1996:161-175.
14. Li J, Billiar TR. Nitric oxide. IV. Determinants of nitric oxide protection and toxicity in liver. Am J Physiol 1999;276:G1069-G1073.
15. Morikawa A, Kato Y, Sugiyama T, Koide N, Chakravortty D, Yoshida T, Yokochi T. Role of nitric oxide in lipopolysaccharide-induced hepatic liver injury in D-galactosamine-sensitized mice as an experimental endotoxic shock model. Infect Immun 1999;67:1018-1024.
16. Hierholzer C, Harbrecht B, Menezes JM, Kane J, MacMicking J, Nathan CF, Peitzman AB, et al. Essential role of nitric oxide in the initiation of the inflammatory response after hemorrhagic shock. J Exp Med 1998;187:917-928.
17. Isobe M, Katsuramaki T, Hirata K, Kimura H, Nagayama M, Matsuno T. Beneficial effects of inducible nitric oxide synthase inhibitor on reperfusion injury in the pig liver. Transplantation 1999;68:803-813.
18. Lake-Bakaar G, Sorbi D, Mazzoccoli V. Nitric oxide and chronic HCV and HIV infections. Dig Dis Sci 2001;46:1072-1076.
19. Rai RM, Lee FY, Rosen A, Yang SQ, Lin HZ, Koteish A, Liew FY. Impaired liver regeneration in inducible nitric oxide synthase-deficient mice. Proc Natl Acad Sci U S A 1998;95:13829-13834.
20. Sass G, Koerber K, Bang R, Guehring H, Tiegs G. Inducible nitric oxide synthase is critical for immune-mediated liver injury in mice. J Clin Invest 2001;107:439-447.
21. Nanji AA, Greenberg SS, Tahan SR, Fogt F, Loscalzo J, Sadrzadeh SM, Xie J, et al. Nitric oxide production in experimental alcoholic liver disease in the rat: Role in protection from injury. Gastroenterology 1995;109:899-907.
22. Bohlinger I, Leist M, Barsig J, Uhlig S, Tiegs G, Wendel A. Interleukin-1 and nitric oxide protect against tumor necrosis factor α-induced liver injury through distinct pathways. Hepatology 1995;22:1829-1837.
23. Muriel P. Nitric oxide protection of rat liver from lipid peroxidation, collagen accumulation, and liver damage induced by carbon tetrachloride. Biochem Pharmacol 1998;56:773-779.
24. Menezes J, Hierholzer C, Watkins SC, Lyons V, Peitzman AB, Billiar TR, Tweardy DJ, et al. A novel nitric oxide scavenger decreases liver injury and improves survival after hemorrhagic shock. Am J Physiol 1999;277:144-151.
25. Thiermermann C, Ruetten H, Wu CC, Vane JR. The multiple organ dysfunction syndrome caused by endotoxin in the rat: Attenuation of liver dysfunction by inhibitors of nitric oxide synthase. Br J Pharmacol 1995;116:2845-2851.
26. Hines IN, Harada H, Bharwani S, Pavlick KP, Hoffman JM, Grisham MB. Enhanced post-ischemic liver injury in iNOS-deficient mice: A cautionary note. Biochem Biophys Res Commun 2001;284:972-976.
27. Kawachi S, Hines IN, Laroux FS, Hoffman J, Bharwani S, Gray L, Leffer D, et al. Nitric oxide synthase and postischemic liver injury. Biochem Biophys Res Commun 2000;276:851-854.
28. Xie Q-W, Whisnant R, Nathan C. Promoter of the mouse gene encoding calcium-independent nitric oxide synthase confers inducibility by interferon gamma and bacterial lipopolysaccharide. J Exp Med 1993;177:1779-1784.
29. MacMicking JD, Nathan C, Hom G, Chartrain N, Fletcher DS, Trumbauer M, Stevens K, et al. Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell 1995;81:641-650.
30. Erickson SL, de Sauvage FJ, Kikly K, Carver-Moore K, Pitts-Meek S, Gillett N, Sheehan KC, et al. Decreased sensitivity to tumor necrosis factor but normal T-cell development in TNF receptor-2-deficient mice. Nature 1994;372:560-563.
31. Schreiber E, Matthias P, Muller MM, Schaffner W. Rapid detection of octamer binding proteins with "mini-extracts," prepared from a small number of cells. Nucleic Acids Res 1989;17:6419.
32. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-254.
33. Kunz P, Walker G, Pfeilschifter J. Dexamethasone differentially affects interleukin 1β- and cyclic AMP-induced nitric oxide synthase mRNA expression in renal mesangial cells. Biochem J 1994;304:337-340.
34. Leeuwenberg JF, Van Tits LJ, Jeunhomme TM, Buurman WA. Evidence for exclusive role in the signalling of tumor necrosis factor p55 receptor and a potentiating function of p75 receptor on human endothelial cells. Cytokine 1995;7:457-462.
35. Ganster RW, Taylor BS, Shao L, Geller DA. Complex regulation of human inducible nitric oxide synthase gene transcription by Stat 1 and NF-kappa B. Proc Natl Acad Sci U S A 2001;98:8638-8643.
36. Volpes R, van den Oord JJ, De Vos R, Depla E, De Ley M, Desmet VJ. Expression of interferon-gamma receptor in normal and pathological human liver tissue. J Hepatol 1991;12:195-202.
37. Collart MA, Belin D, Vassalli JD, de Kossodo S, Vassalli P. Gamma interferon enhances macrophage transcription of the tumor necrosis factor/cachectin, interleukin 1, and urokinase genes, which are controlled by short-lived repressors. J Exp Med 1986;164:2113-2118.
38. Schweyer S, Mihm S, Radzun HJ, Hartmann H, Fayyazi A. Liver infiltrating T lymphocytes express interferon gamma and inducible nitric oxide synthase in chronic hepatitis C virus infection. Gut 2000;46:255-259.
39. Grell M, Wajant H, Zimmermann G, Scheurich P. The type 1 receptor (CD120a) is the high-affinity receptor for soluble tumor necrosis factor. Proc Natl Acad Sci U S A 1998;95:570-575.
40. Wolf D, Hallmann R, Sass G, Sixt M, Kiisters S, Fregien B, Trautwein T, Tiegs G. TNF-α-induced expression of adhesion molecules in the liver is under the control of tumor necrosis factor receptor 1 - Relevance for murine hepatitis. J Immunol 2001;166:1300-1307.
41. Xie QW, Kashiwabara Y, Nathan C. Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase. J Biol Chem 1994;269:4705-4708.
42. Barnes PJ, Karim M. NF-κB - A pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 1997;336:1066-1071.
43. May MJ, Ghosh S. Signal transduction through NF-kappa B. Immunol Today 1998;19:80-88.
44. Hsu H, Xiong J, Goeddel DV. The TNF receptor 1-associated protein TRADD signals cell death and NF-κB activation. Cell 1995;81:495-504.
45. Rothe M, Wong SC, Henzel WJ, Goeddel DV. A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kD tumor necrosis factor receptor. Cell 1994;78:681-692.
46. Martin E, Nathan C, Xie Q. Role of interferon regulatory factor 1 in induction of nitric oxide synthase. J Exp Med 1994;180:977-984.
47. Díaz-Guerra M, Velasco M, Martín-Sanz P, Boscá L. Evidence for common mechanisms in the transcriptional control of type II nitric oxide synthase in isolated hepatocytes. Requirement of NF-kappaB activation after stimulation with bacterial cell wall products and phorbol esters. J Biol Chem 1996;271:30114-30120.
48. Spink J, Cohen J, Evans TJ. The cytokine responsive vascular smooth muscle cell enhancer of inducible nitric oxide synthase: Activation by nuclear factor-κB. J Biol Chem 1995;270:29541-29547.
49. Lui SF, Ye X, Malik AB. Inhibition of NF-κB activation by pyrrolidine dithiocarbamate prevents in vivo expression of proinflammatory genes. Circulation 1999;100:1330-1337.
50. Liu SF, Ye X, Malik AB. In vivo inhibition of nuclear factor-kappa B activation prevents inducible nitric oxide synthase expression and systemic hypotension in a rat model of septic shock. J Immunol 1997;159:3976-3983.